Skip to content
IPOandMore
  • Home
  • IPO/OFS/Stocks
    • IPO Review
    • Post IPO Analysis
    • Stock Analysis
  • Buybacks / Spl Situations
    • Recent Buybacks (Last 50)
    • All BuyBacks
    • Buyback Review
    • Special Situations
  • NCDs / Fixed Income
    • Fixed Income
    • NCD ReviewNCD Analysis & Review
  • Mutual Funds
  • Personal Finance
  • NRI
  • About
  • Toggle website search
Menu Close
  • Home
  • IPO/OFS/Stocks
    • IPO Review
    • Post IPO Analysis
    • Stock Analysis
  • Buybacks / Spl Situations
    • Recent Buybacks (Last 50)
    • All BuyBacks
    • Buyback Review
    • Special Situations
  • NCDs / Fixed Income
    • Fixed Income
    • NCD Review
  • Mutual Funds
  • Personal Finance
  • NRI
  • About
  • Toggle website search

IPO/OFS/Stocks

  1. Home>
  2. IPO/OFS/Stocks>
  3. Page 51

LTTS OFS Review

  • Post author:[email protected]
  • Post published:June 4, 2019
  • Post category:OFS Review
  • Post comments:0 Comments

L&T Technology Services (LTTS) promoter Larsen & Toubro plans to sell its 3.88 percent stake in the LTTS. The LTTS OFS comprises sale of up to 40.34 lakh shares at…

Continue ReadingLTTS OFS Review

RNAM OFS (Reliance Nippon Life Asset Management OFS)

  • Post author:[email protected]
  • Post published:May 24, 2019
  • Post category:OFS Review
  • Post comments:0 Comments

Reliance Nippon Life Asset Management OFS comprises sale by Reliance Capital for 5.25 per cent of the paid up equity with an additional green shoe option of 3.41 per cent…

Continue ReadingRNAM OFS (Reliance Nippon Life Asset Management OFS)

HDFC LIfe OFS May 2019

  • Post author:[email protected]
  • Post published:May 3, 2019
  • Post category:OFS Review
  • Post comments:0 Comments

HDFC Standard Life OFS proposes to sell up to 3,60,00,000 equity shares on May 3, 2019 for non-retail investors only and on May 6, 2019, for retail investors and for…

Continue ReadingHDFC LIfe OFS May 2019

Neogen Chemicals IPO: Brokerage Views & Run up to IPO

  • Post author:[email protected]
  • Post published:April 23, 2019
  • Post category:IPO Review
  • Post comments:0 Comments

Continue ReadingNeogen Chemicals IPO: Brokerage Views & Run up to IPO

Neogen Chemicals IPO: Brokerage Views & Run up to IPO

  • Post author:[email protected]
  • Post published:April 23, 2019
  • Post category:IPO Review
  • Post comments:0 Comments

Continue ReadingNeogen Chemicals IPO: Brokerage Views & Run up to IPO

Neogen Chemicals IPO Review

  • Post author:[email protected]
  • Post published:April 23, 2019
  • Post category:IPO Review
  • Post comments:0 Comments

Neogen Chemicals IPO is looking to raise Rs 70 crore by issuing fresh equity shares and also comprises of secondary share sale worth Rs 69 crore by the promoter group.…

Continue ReadingNeogen Chemicals IPO Review

MetroGlobal Buyback Review

  • Post author:[email protected]
  • Post published:April 8, 2019
  • Post category:OFS Review
  • Post comments:0 Comments

Metroglobal Limited had informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/03/2019 ,inter alia, to consider the proposal of Buy-back of Equity…

Continue ReadingMetroGlobal Buyback Review

Polycab IPO: Brokerage Views & Run up to IPO

  • Post author:[email protected]
  • Post published:April 5, 2019
  • Post category:IPO Review
  • Post comments:0 Comments

This post on Polycab IPO tries to bring out consolidated brokerage views , subscription information, Grey Market Premium (GMP) and anchor investor information where applicable. The information collated from various…

Continue ReadingPolycab IPO: Brokerage Views & Run up to IPO

Polycab IPO: Brokerage Views & Run up to IPO

  • Post author:[email protected]
  • Post published:April 5, 2019
  • Post category:IPO Review
  • Post comments:0 Comments

This post on Polycab IPO tries to bring out consolidated brokerage views , subscription information, Grey Market Premium (GMP) and anchor investor information where applicable. The information collated from various…

Continue ReadingPolycab IPO: Brokerage Views & Run up to IPO

Metropolis Healthcare IPO: Brokerage Views & Run Up to IPO

  • Post author:[email protected]
  • Post published:April 3, 2019
  • Post category:IPO Review
  • Post comments:0 Comments

This post on Metropolis Healthcare IPO tries to bring out consolidated brokerage views , subscription information, Grey Market Premium (GMP) and anchor investor information where applicable. The information collated from…

Continue ReadingMetropolis Healthcare IPO: Brokerage Views & Run Up to IPO

Metropolis Healthcare IPO: Brokerage Views & Run Up to IPO

  • Post author:[email protected]
  • Post published:April 3, 2019
  • Post category:IPO Review
  • Post comments:0 Comments

This post on Metropolis Healthcare IPO tries to bring out consolidated brokerage views , subscription information, Grey Market Premium (GMP) and anchor investor information where applicable. The information collated from…

Continue ReadingMetropolis Healthcare IPO: Brokerage Views & Run Up to IPO

Metropolis Healthcare IPO Review

  • Post author:[email protected]
  • Post published:April 1, 2019
  • Post category:IPO Review
  • Post comments:0 Comments

Metropolis Healthcare IPO comprises offer for sale of 13.7 million equity shares, with a face value of ₹2 per share in a price band of Rs. 877-880. Metropolis Healthcare IPO…

Continue ReadingMetropolis Healthcare IPO Review
  • Go to the previous page
  • 1
  • …
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • …
  • 81
  • Go to the next page

Archives

Categories

Copyright - WordPress Theme by OceanWP